Literature DB >> 11787849

Benign tumors of the breast with multinucleated stromal giant cells. Immunohistochemical analysis of six cases and review of the literature.

A Ryska1, C Reynolds, G L Keeney.   

Abstract

The authors present six cases of benign tumors of the breast with numerous multinucleated stromal giant cells (MSGC). All six patients were women aged 37-70 years (mean 48 years), presenting clinically with a breast mass 1.0-3.8 cm in size (mean 1.9 cm; median 1.5 cm). By standard H&E examination, all cases showed the presence of numerous MSGC haphazardly dispersed within the tumor stroma. Three cases revealed MSGC merging into the surrounding adipose tissue simulating infiltrative growth. The MSGC appeared to have multiple nuclei (5 to 25) with fine chromatin and sporadic small nucleoli. Their cytoplasm was inconspicuous. The MSGC expressed vimentin only and to lesser extent CD34. These cells were negative for muscle markers, keratins, S-100 protein, vascular markers, CD68 and hormone receptors. Interestingly, the majority of MSGC and mononuclear stromal cells showed reactivity for p53 protein and Ki-67 proliferation antigen. All patients were treated by simple excision and remain free of recurrence (mean 70 months, median 48 months.). The reactivity of p53 in MSGC and mononuclear stromal cells may play a key role in linking these two cell types. Nonetheless, the presence of MSGC does not alter prognosis of otherwise typical benign lesions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11787849     DOI: 10.1007/s004280100470

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  8 in total

1.  Infiltrating mammary carcinoma with osteoclast-like giant cells.

Authors:  Amy Stratton; Timothy P Plackett; Christina M Belnap; Kevin M Lin-Hurtubise
Journal:  Hawaii Med J       Date:  2010-12

Review 2.  Benign breast diseases.

Authors:  Carine Courtillot; Geneviève Plu-Bureau; Nadine Binart; Corinne Balleyguier; Brigitte Sigal-Zafrani; Vincent Goffin; Frédérique Kuttenn; Paul A Kelly; Philippe Touraine
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

3.  Multinucleated giant cells from fibroblast cultures.

Authors:  Dolly J Holt; David W Grainger
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

Review 4.  Breast carcinoma with osteoclastic giant cells: case report and review of the literature.

Authors:  Ya Niu; Xin Liao; Xuenong Li; Liang Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

5.  Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.

Authors:  Aditya Parekh; Subhayan Das; Sheetal Parida; Chandan Kanta Das; Debabrata Dutta; Sanjaya K Mallick; Pei-Hsun Wu; B N Prashanth Kumar; Rashmi Bharti; Goutam Dey; Kacoli Banerjee; Shashi Rajput; Deblina Bharadwaj; Ipsita Pal; Kaushik Kumar Dey; Yetirajam Rajesh; Bikash Chandra Jena; Angana Biswas; Payel Banik; Anjan K Pradhan; Swadesh K Das; Amit Kumar Das; Santanu Dhara; Paul B Fisher; Denis Wirtz; Gordon B Mills; Mahitosh Mandal
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

6.  Multinucleated floret-like giant cells in sporadic and NF1-associated neurofibromas: a clinicopathologic study of 94 cases.

Authors:  Gaetano Magro; Paolo Amico; Giada Maria Vecchio; Rosario Caltabiano; Marine Castaing; Denisa Kacerovska; Dmitry V Kazakov; Michal Michal
Journal:  Virchows Arch       Date:  2009-11-25       Impact factor: 4.064

7.  A diagnostic dilemma in breast pathology--benign fibroadenoma with multinucleated stromal giant cells.

Authors:  Helen M Heneghan; Sean T Martin; Mary Casey; Igdam Tobbia; Fadel Benani; Kevin M Barry
Journal:  Diagn Pathol       Date:  2008-08-01       Impact factor: 2.644

8.  P53 Expression in benign Breast Disease Development: A Systematic Review.

Authors:  Rafaela Soares Senra da Costa; Ilce Ferreira Da Silva
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.